Introduction
============

There have been extensive studies published in the literature on the problem of heart failure with normal or preserved ejection fraction (HFpEF) defined as ejection fraction (EF) \>50%, and about half the patients with symptoms of heart failure (HF) have normal or near-normal EF.[@b1-cmc-suppl.1-2015-111]--[@b6-cmc-suppl.1-2015-111] It was first reported by Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] that patients with aortic stenosis can have decrease in longitudinal shortening and wall thickening of the left ventricle, while the EF remains within normal limits because of intrinsic factors and/or left ventricular geometry.[@b10-cmc-suppl.1-2015-111],[@b11-cmc-suppl.1-2015-111] One should not lose sight of the fact that HF is complex process that involves interacting factors like the intrinsic state and metabolism of the myocardium, relaxation mechanism, ventricular filling and ejection, preload, and afterload. In this study we look at HFpEF from one angle, it is the relation between EF and indexes derived from the end-systolic pressure--volume relation (ESPVR) that in some way reflects the state of the myocardium.

When the myocardium reaches its maximum state of activation during the contraction phase, the relation between pressure and volume is known as the ESPVR as explained in more detail in the next section. The application of the ESPVR to clinical problems is not new.[@b12-cmc-suppl.1-2015-111]--[@b18-cmc-suppl.1-2015-111] In the case of a linear approximation of the ESPVR, studies have focused usually on the use of the maximum slope *E~max~* and the volume axis intercept *V~om~* for assessing the performance of the left ventricle, for a review see[@b13-cmc-suppl.1-2015-111],[@b19-cmc-suppl.1-2015-111] and a tutorial introduction can be found in.[@b20-cmc-suppl.1-2015-111] The interesting observation that the curvilinearity of the ESPVR contains information that reflects in some way the contractility of the myocardium has been reported,[@b21-cmc-suppl.1-2015-111]--[@b25-cmc-suppl.1-2015-111] a point that will be given some attention in this study. Mathematical relations between EF and the parameters describing the ESPVR have been discussed in previous studies by the author both in case of linear ESPVR[@b26-cmc-suppl.1-2015-111],[@b27-cmc-suppl.1-2015-111] and in case of nonlinear ESPVR.[@b28-cmc-suppl.1-2015-111] It was shown that the EF is just one of several indexes that can be derived from the ESPVR for assessing the state of the myocardium. In this study, some of these indexes are reviewed and new applications to clinical data published in the study by Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] are presented that show the consistency of the mathematical formalism used. Moreover, it is shown that when ratios of parameters involving pressures or areas are used, the indexes derived from the ESPVR can be calculated in a noninvasive way from volume measurements only, for instance, by using echocardiography or magnetic resonance imaging. The mathematical formalism developed applies also to the right ventricle[@b29-cmc-suppl.1-2015-111]--[@b31-cmc-suppl.1-2015-111] and possibly to the four chambers of the heart, and the discussion in this study is confined to the left ventricle. A minimal number of equations are used in the main text to describe the properties of the ESPVR, and more complex mathematical formalism is confined to Supplementary Material.

Mathematical Model
==================

Unlike most studies on the topic, our approach to the problem was mainly theoretical.[@b25-cmc-suppl.1-2015-111]--[@b28-cmc-suppl.1-2015-111],[@b31-cmc-suppl.1-2015-111]--[@b39-cmc-suppl.1-2015-111] As shown in [Figure 1](#f1-cmc-suppl.1-2015-111){ref-type="fig"}, the left ventricle is represented as a thick-walled cylinder contracting symmetrically, a helical muscular fiber in the myocardium is projected as a dotted circle on the cross-section. Because of the symmetry assumption, a radial active force/unit volume of the myocardium *D*(*r*) is generated, and it will develop an active pressure on the inner surface of the myocardium (endocardium), expressed as follows $$\int_{a}^{b}{D(r)dr = \overline{D}h}$$

The thickness of the myocardium is given by *h* = *b* -- *a*, where *a* = inner radius of the myocardium, *b* = outer radius, and $\overline{D}$ is an average radial active force/unit volume of the myocardium calculated by applying the mean value theorem. In a quasi-static approximation of the contraction (inertia and viscous forces neglected), we can write $\overline{D}h \approx P_{iso}$, where *P~iso~* is the notation used by physiologists to indicate the isovolumic pressure developed by the myocardium in a nonejecting contraction. Near end-systole when the myocardium reaches its maximum state of activation with maximum isovolumic pressure *P~isom~* and left ventricular pressure *P~m~*, the equilibrium of forces on the inner surface of the myocardium can be expressed as follows $$P_{isom} - P_{m} = E_{2m}(V_{ed} - V_{m})$$

*P~m~* is assumed constant during the ejection phase for simplicity as shown in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}, the corresponding left ventricular volume is *V~m~* ≈ *V~es~* (end-systolic volume when *dV*/*dt* = 0), *V~ed~* is the end-diastolic volume (when *dV*/*dt* = 0), and *SV* ≈ *V~ed~* -- *V~m~* is the stroke volume. The elastance coefficient *E*~2~*~m~* = tanβ~2~ is the slope of the line CD shown in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}. If *P~isom~* is kept constant in [Equation (2)](#fd2-cmc-suppl.1-2015-111){ref-type="disp-formula"} and the point *D* with coordinates (*P~m~*, *V~m~*) is varied from (0, *V~om~*) to (*P~isom~*, *V~ed~*) in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"} (as if a balloon was inflated against a constant *P~isom~*), we get the ESPVR represented by the curve BDC. The ESPVR curve is tangent to the *P*-*V* loop at the point (*P~m~*, *V~m~*), and the *P*-*V* loop of a normal ejecting contraction is represented in a simplified way in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"} by the rectangle *V~ed~D*~1~*DV~m~*. Two other relations can be obtained by splitting [Equation (2)](#fd2-cmc-suppl.1-2015-111){ref-type="disp-formula"} as follows $$P_{m} = E_{1m}(V_{m} - V_{om}) = E_{2m}(V_{m} - V_{o2})$$ $$P_{isom} = E_{m}(V_{ed} - V_{om}) = E_{2m}(V_{ed} - V_{o2})$$

The elastance coefficients *E*~1~*~m~* = tanβ~1~ (slope of the line BD) and *E~m~* = tanα (slope of the line BC) are shown in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"} as well as the intercept *V~om~* of the curvilinear ESPVR with the volume axis; *V~o~*~2~ corresponds to the intercept of the line CD with the volume axis. Unlike the linear ESPVR that is described by one slope *E~max~*,[@b33-cmc-suppl.1-2015-111]--[@b35-cmc-suppl.1-2015-111] the nonlinear ESPVR (curve BDC in [Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}) can be described by several slopes that are summarized as follows: $$tan\alpha = \frac{P_{isom}}{V_{ed} - V_{om}} = \text{slope\ of\ the\ line\ CB}$$ $$e_{am} = \frac{p_{m}}{SV} = \text{arterial\ elastance\ near\ end\ systole}$$ $$tan\beta_{1} = \frac{P_{s} - P_{m}}{SV} = \frac{P_{s}}{V_{ed} - V_{om}} = \frac{P_{m}}{V_{m} - V_{om}}$$where *P~s~* corresponds to the ordinate of the intercept of the line BD with the vertical line AC (not shown in [Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}). We also have $$tan\beta_{2} = \frac{P_{isom} - P_{m}}{SV} = \frac{P_{isom}}{V_{ed} - V_{o2}} = \frac{P_{m}}{V_{m} - V_{o2}}$$where *V~o~*~2~ corresponds to the intercept of the line CD with the volume axis. Finally, $$tan\gamma = \frac{dP_{m}}{dV_{m}} = \frac{P_{t} - P_{m}}{SV} = \frac{P_{t}}{V_{ed} - V_{ot}} = \frac{P_{m}}{V_{m} - V_{ot}}$$is the slope of the tangent to the ESPVR at point D with coordinates (*P~m~*, *V~m~*), *P~t~* corresponds to the ordinate of the intercept of the tangent with the vertical line AC, and *V~ot~* corresponds to the intercept of the tangent with the volume axis. $$tan\gamma_{1} = \text{tangent\ to\ the\ ESPVR\ at\ point\ B}$$ $$tan\gamma_{3} = \text{tangent\ to\ the\ ESPVR\ at\ point\ C}$$

Expressions for tanγ, tanγ~1~, and tanγ~3~ are given in the Supplementary Material and in Shoucri.[@b28-cmc-suppl.1-2015-111]

Stroke volume
-------------

The following relations can be easily derived from the preceding equations: $$\frac{tan\beta_{2}}{e_{am} + tan\beta_{2}} = \frac{SV}{V_{ed} - V_{o2}} = \frac{P_{isom} - P_{m}}{P_{isom}}$$ $$\frac{tan\gamma}{e_{am} + tan\gamma} = \frac{SV}{V_{ed} - V_{ot}} = \frac{P_{t} - P_{m}}{P_{t}}$$ $$\frac{tan\beta_{1}}{e_{am} + tan\beta_{1}} = \frac{SV}{V_{ed} - V_{om}} = \frac{P_{s} - P_{m}}{P_{s}}$$

[Equation (6)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"} show how the ratios of the afterload measured by the stroke volume *SV* to the preload measured by *V~ed~* -- *V~o~*~2~, *V~ed~* -- *V~ot~*, or *V~ed~* -- *V~om~* are determined by the ratios of the slopes describing the ESPVR and how the inotropic state of the myocardium as expressed by the peak isovolumic pressure *P~isom~* is related to the parameters describing the ESPVR ([Equation (6a)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"}). These complex relations are similar to the relation derived in the case of a linear ESPVR: *SV* = (*V~ed~* -- *V~o~*) *E~max~*/(*e~am~* + *E~max~*) (see Sunagawa et al.[@b18-cmc-suppl.1-2015-111]). For the sake of completeness, we give also the following relation that can be derived for a cylindrical model and that shows the influence of the geometry on the calculation of SV: $$SV = SVR + \frac{1}{8}V_{\omega}\Delta\left( \frac{h}{R} \right)$$

SVR is the stroke volume of the mid-wall cylinder with radius *R* = (*a* + *b*)/2, *V*~ω~ is the volume of the myocardium assumed constant and ∆(*h*/*R*) is the variation of the ratio *h*/*R* between end-diastole and end-systole. [Equations (6)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"} and [(7)](#fd15-cmc-suppl.1-2015-111){ref-type="disp-formula"} reflect the complex interrelation between several factors affecting the SV, and consequently, the *EF* = *SV*/*V~ed~*. [Equation (7)](#fd15-cmc-suppl.1-2015-111){ref-type="disp-formula"} shows that ratios of volumes like *SV*/*V*~ω~ or *SVR*/*V*~ω~ can be calculated from transversal M-mode echocardiographic measurement of *h*/*R* as explained in Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111]

Stroke work
-----------

The stroke work *SW* ≈ *P~m~* (*V~ed~* -- *V~m~*) is a measure of the energy delivered to the systemic circulation during the contraction phase. In [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}, when the point D with coordinates (*P~m~*, *V~m~*) moves along the ESPVR (curve BDC), the stroke work *SW* reaches its maximum value *SW~x~*, with corresponding values *P~m~* = *P~mx~*, *V~m~* = *V~mx~*, when the following condition is satisfied: $$\frac{d(SW)}{dV_{m}} \approx \frac{d}{dV_{m}}\lbrack P_{m}(V_{ed} - V_{m})\rbrack = (V_{ed} - V_{m})\frac{dp_{m}}{dV_{m}} - P_{m} = 0$$

By using [Equations (5b)](#fd6-cmc-suppl.1-2015-111){ref-type="disp-formula"} and [(5e)](#fd9-cmc-suppl.1-2015-111){ref-type="disp-formula"}, we get when *SW* = *SW~x~* $$tan\gamma_{x} = e_{amx}$$

A similar relation has been obtained in the case of a linear ESPVR.[@b26-cmc-suppl.1-2015-111],[@b27-cmc-suppl.1-2015-111],[@b34-cmc-suppl.1-2015-111],[@b35-cmc-suppl.1-2015-111] The stroke work reserve SWR is defined as in the case of linear ESPVR as follows: $$SWR = SW_{x} - SW \approx P_{mx}(V_{ed} - V_{mx}) - P_{m}(V_{ed} - V_{m})$$

SWR is an important index to assess the ventricular function. It measures the ability of the ventricle to increase its output as a result of an increase in load demand measured by an increase in *P~m~*. Similar to the linear model of ESPVR,[@b26-cmc-suppl.1-2015-111],[@b27-cmc-suppl.1-2015-111],[@b34-cmc-suppl.1-2015-111],[@b35-cmc-suppl.1-2015-111] one can distinguish the following cases in studying the performance of the ventricle: tanγ \> *e~am~*, which corresponds to *P~m~* \< *P~mx~*, *V~m~* \< *V~mx~*, and *SW* \< *SW~x~*. It corresponds to a normal state of the ventricular function. An increase in *P~m~* due to an increase in load demand results in a corresponding increase in the stroke work *SW*.tanγ~x~ ≈ *e~amx~*, which corresponds to *P~m~* ≈ *P~mx~*, *V~m~* ≈ *V~mx~*, and *SW* ≈ *SW~x~*. It corresponds to a mildly depressed state of the heart. An increase in Pm due to an increase in load demand results in a decrease in SW, resulting in cardiac insufficiency.tanγ \< *e~am~*, which corresponds to *P~m~*.\>. *P~mx~*, *V~m~* \> *V~mx~*, and *SW* \< *SW~x~*. It corresponds to a severely depressed state of the heart. An increase in *P~m~* due to an increase in load demand results in a severe decrease in *SW* causing severe cardiac insufficiency.

Experimental verification of these results for the left ventricle can be found in Asanoi et al.[@b12-cmc-suppl.1-2015-111] and Burkhoff and Sagawa[@b40-cmc-suppl.1-2015-111] and for the right ventricle in Brimioulle et al.[@b29-cmc-suppl.1-2015-111]

Applications to Clinical Data
=============================

Clinical data measured by M-mode echocardiography on patients corresponding to five clinical groups are taken from results published in Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] They have been used to calculate the results shown in [Table 1](#t1-cmc-suppl.1-2015-111){ref-type="table"} and in the figures. The echocardiographic measurements consisted in the transversal dimensions of the myocardium (inner and outer radii, thickness). The longitudinal axis was calculated in Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] by angiography for the purpose of validating the equations used. A cylindrical model was used to calculate the volume of the myocardium *V~ω~* as reproduced in the second column of [Table 1](#t1-cmc-suppl.1-2015-111){ref-type="table"}. A cylindrical model was also used to calculate *V~ed~* and *V~m~* in [Table 1](#t1-cmc-suppl.1-2015-111){ref-type="table"}. However, it should be clear that calculating ratios of volumes, ratios of slopes, ratios of areas under the ESPVR, or ratios of pressures can be done in a noninvasive way as is evidenced from [Equation (6)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"}, the equations given in the Supplementary Material based on a cylindrical model, and as explained in Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] Moreover, one can find several studies about the estimation of the ventricular volume or the length of the longitudinal axis from measurement of the transversal dimensions of the myocardium.

The left ventricular pressure *P~m~* has not been measured with the data given in Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] Results of calculation for *P~isom~*/*P~m~* and *P~t~*/*P~m~* given in [Table 1](#t1-cmc-suppl.1-2015-111){ref-type="table"} were obtained by using [Equation (6)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"}. Calculation of *V~om~*, *V~o~*~2~, *V~ot~*: The calculation of the intercept *V~om~* of the ESPVR with the volume axis is carried out by using the Newton--Raphson method to calculate the root of a nonlinear equation as explained in Shoucri.[@b28-cmc-suppl.1-2015-111],[@b36-cmc-suppl.1-2015-111]--[@b39-cmc-suppl.1-2015-111] The algorithm also calculates *V~o~*~2~ and *V~ot~* by using, for instance, [Equations (4)](#fd4-cmc-suppl.1-2015-111){ref-type="disp-formula"}, [(5d)](#fd8-cmc-suppl.1-2015-111){ref-type="disp-formula"}, and [(5e)](#fd9-cmc-suppl.1-2015-111){ref-type="disp-formula"}, and the results are shown in [Table 1](#t1-cmc-suppl.1-2015-111){ref-type="table"}. [Figure 3](#f3-cmc-suppl.1-2015-111){ref-type="fig"} shows the relation between *y* = (*P~isom~* -- *P~m~*)/*P~m~* against *x* = *SV*/(*V~m~* − *V~o~*~2~) derived from [Equation (6a)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"}. It was found that transforming an index *x* into the form *x*1 = *x*/std(*x*) (std = standard deviation, in this case std(*x*1) = 1 and mean(*x*1) = mean(*x*)/std(*x*)) or into the form *x*1 = (*x* + mean(*x*))/std(*x*) (in this case std(*x*1) = 1and mean(*x*1) = 2 mean(*x*)/std(*x*)), can give better separate display of clinical groups as shown in [Figure 3](#f3-cmc-suppl.1-2015-111){ref-type="fig"}.Two-dimensional display of data allows better segregation between clinical groups. This property is further illustrated in [Figure 4](#f4-cmc-suppl.1-2015-111){ref-type="fig"}, where the plotting of *EF* versus *EF*/std(*EF*), and (*V~m~* -- *V~o~*~2~)/*V~o~*~2~ versus \[(*V~m~* -- *V~o~*~2~)/*V~o~*~2~\]/std\[(*V~m~* -- *V~o~*~2~)/*V~o~*~2~\] is shown. Notice for instance in [Figure 4](#f4-cmc-suppl.1-2015-111){ref-type="fig"} (left) that the projection of the data along the horizontal axis (*EF*) or vertical axis (*EF*/std(*EF*)) introduces overlap between the different clinical groups, but the two-dimensional display shows a clear segregation between the five clinical groups. However, we introduce in this way a problem of classification, given a new piece of data how to choose the standard deviation to place it in one of the groups displayed. But there are other statistical methods that can be used for classification, like cross-validation, bootstrap analysis, and areas under ROC curves.Bivariate analysis of data: In [Figure 5](#f5-cmc-suppl.1-2015-111){ref-type="fig"} the same parameters are used in the left side and right side; however, the grouping of data is different on the left side and the right side depending on the clinical groups considered. Notice in [Figure 5](#f5-cmc-suppl.1-2015-111){ref-type="fig"} (left) that values of (*P~isom~* -- *P~m~*)/*TW* (resultant pressure on the endocardium/total area under the ESPVR) appear enhanced for some cases of aortic stenosis with respect to the normal group and that smaller values of (*P~isom~* -- *P~m~*)/*TW* correspond to larger values of SV indicating a possible increase in time in order to achieve ejection.Stroke work reserve, *SWR*: [Figure 6](#f6-cmc-suppl.1-2015-111){ref-type="fig"} (left) shows a relation between *SWR*/*SW* and *EF* = *SV*/*V~ed~*. [Figure 6](#f6-cmc-suppl.1-2015-111){ref-type="fig"} (right) shows a relation between *SWR*/*SW* and tanγ/*e~am~*. Notice from [Figure 6](#f6-cmc-suppl.1-2015-111){ref-type="fig"} (left) that *SWR*/*SW* → 0 for *EF* ≈ 0.33 ≈ 1/3, and from [Figure 6](#f6-cmc-suppl.1-2015-111){ref-type="fig"} (right) that *SWR*/*SW* → 0 when tanγ/*e~am~* → 1 in agreement with [Equations (8)](#fd16-cmc-suppl.1-2015-111){ref-type="disp-formula"} and [(9)](#fd17-cmc-suppl.1-2015-111){ref-type="disp-formula"}.Occurrences of HF: [Figure 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"} (left) shows the percentage of occurrences of HF plotted against LVEF (left ventricular ejection fraction \[%\], data taken from Figure 1.1 of Da Mota[@b3-cmc-suppl.1-2015-111]) (see also a similar graph in Curtis et al.[@b2-cmc-suppl.1-2015-111]). We have then calculated a least square fit of the data that is shown by the solid curve in [Figure 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"} (left). This least square fit was then used to calculate the percentage of occurrences of HF for the EFs of the five clinical groups considered in this study. The results are shown in [Figure 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"} (right). The results on both sides of [Figure 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"} indicate a minimum of occurrences of HF around *EF* ≈ 0.66 ≈ 2/3. [Figure 8](#f8-cmc-suppl.1-2015-111){ref-type="fig"} (left) shows the calculated percentage of occurrences of HF plotted versus 100\*SWR/SW for the five clinical cases considered in this study. A minimum of the curve is observed around *SWR*/*SW* ≈ 0.3. [Figure 8](#f8-cmc-suppl.1-2015-111){ref-type="fig"} (right) shows the calculated percentage of occurrences of HF plotted versus 100\*(*V~ed~* -- *V~mx~*)/*SV*, a minimum of the curve is observed around (*V~ed~* -- *V~mx~*)/*SV* ≈ 0.79 (or *SV*/(*V~ed~* -- *V~mx~*) ≈ 1.25). In [Figure 9](#f9-cmc-suppl.1-2015-111){ref-type="fig"} (left), the percentage of occurrences of HF/respective standard deviation of each group is plotted versus 100\*EF for the five clinical groups considered in this study, and in [Figure 9](#f9-cmc-suppl.1-2015-111){ref-type="fig"} (right) a similar plot versus 100\*SWR/SW is shown. The highest curve in the graphics (normal case) results from the fact that this clinical group has the smallest standard deviation. Notice that in the five clinical cases shown in [Figure 9](#f9-cmc-suppl.1-2015-111){ref-type="fig"}, the minima of the curves occur around *EF* ≈ 0.67 and around *SWR*/*SW* ≈ 0.3. [Figure 10](#f10-cmc-suppl.1-2015-111){ref-type="fig"} (left) shows the calculated percentage of occurrences of *HF* plotted versus 100\**SV*/(*V~ed~* -- *V~om~*) for the five clinical cases considered in this study, a minimum of the curve is observed around *SV*/(*V~ed~* -- *V~om~*) ≈ 0.85. [Figure 10](#f10-cmc-suppl.1-2015-111){ref-type="fig"} (right) shows the calculated percentage of occurrences of HF plotted versus 100\**SV*/(*V~ed~* -- *V~o~*~2~), a minimum of the curve is observed around *SV*/(*V~ed~* -- *V~o~*~2~) ≈ 0.57.

Discussion
==========

This study has shown that the EF is just one of a rich collection of indexes that can be derived from the parameters describing the nonlinear ESPVR as shown in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}. These parameters in some way reflect the state of the myocardium. The results of this study indicate that there is not a single index that can give a full discriminate separation between all clinical groups. Good segregation from the normal group depends on the clinical group and the index used. Some interesting results have been obtained: Two-dimensional graphic representations of data by using two indexes can give better segregation between clinical groups (instead of using just one index like EF), which suggests the idea that bivariate (or multivariate) analysis may be a better approach to study the classification of clinical data than univariate analysis. In particular instead of using an index *x*, the use of *x*/std(*x*) or (*x* + mean(*x*))/std(*x*) can give better segregation between clinical groups (see Figs.).When the left ventricular pressure *P~m~* is not measured, the factor *k~w~* cannot be calculated in [Equations (A1)](#fd19-cmc-suppl.1-2015-111){ref-type="disp-formula"}--[(A7)](#fd25-cmc-suppl.1-2015-111){ref-type="disp-formula"} in the Supplementary Material and only ratios of quantities involving pressures or areas can be calculated. This is also evident from [Equation (6)](#fd12-cmc-suppl.1-2015-111){ref-type="disp-formula"}. These ratios may have a reduced sensitivity to reflect the intrinsic state of the myocardium by eliminating *k~w~*. But this drawback can be compensated by the fact that the obtained indexes can be calculated in a noninvasive way. Notice that *P~m~* can be approximated, for instance, by using the peak blood pressure.Numerical values of some indexes given at the end of the previous section should be considered as preliminary results that need further experimental confirmation. However, there is a consistency in the results obtained, for instance, the stroke work reserve *SWR* = *SW~x~* -- *SW* → 0 for tanγ/*e~am~* → 1 (see [Fig. 6](#f6-cmc-suppl.1-2015-111){ref-type="fig"} \[right\]) has been verified in a previous study on other clinical data.[@b28-cmc-suppl.1-2015-111] Also from the study of linear ESPVR[@b26-cmc-suppl.1-2015-111],[@b27-cmc-suppl.1-2015-111],[@b34-cmc-suppl.1-2015-111],[@b35-cmc-suppl.1-2015-111] and experimental results,[@b12-cmc-suppl.1-2015-111],[@b29-cmc-suppl.1-2015-111],[@b40-cmc-suppl.1-2015-111] we know that the ratio *E~max~*/*e~am~* (maximum elastance/arterial elastance) for the normal state of the heart is of order of ≈ 2, which corresponds to the results of this study that show that tanα/*e~am~* is varying between 1.75 and 2.1 (see [Table 1](#t1-cmc-suppl.1-2015-111){ref-type="table"}).The variation of percentage of occurrences of HF with various indexes presented in [Figures 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"}--[10](#f10-cmc-suppl.1-2015-111){ref-type="fig"} shows consistency. Notice that the normal group (\*) appears around the minimum of all the curves shown in the [Figures 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"} (right) to 10, which is an indication of the consistency of the calculations. The HF patients contain cases with HFpEF (also referred to as diastolic HF), as is evidenced from the overlap around EF ≈ 0.67 between normal group and cases of cardiomyopathies shown in [Figures 7](#f7-cmc-suppl.1-2015-111){ref-type="fig"}--[10](#f10-cmc-suppl.1-2015-111){ref-type="fig"}.Notice that the formalism used in this study has allowed the classification of the performance of the ventricle in normal, mildly depressed, and severely depressed state as discussed at the end of Mathematical Model section, and the introduction of the concept of stroke work reserve (SWR) that can help in assessing the ventricular function. The introduction of the isovolumic pressure *P~isom~* in the formalism describing the PVR as in [Equation (2)](#fd2-cmc-suppl.1-2015-111){ref-type="disp-formula"} is an important feature of the mathematical formalism used. Discussion of these results can be found in previous publications.[@b26-cmc-suppl.1-2015-111]--[@b28-cmc-suppl.1-2015-111],[@b34-cmc-suppl.1-2015-111],[@b35-cmc-suppl.1-2015-111]This study has shown relations between stroke volume *SV* (and *EF* = *SV*/*V~ed~*) and parameters describing the ESPVR, which opens a new and interesting direction of research in the study of the problem of HFpEF. Both the diastolic and systolic state of the myocardium will influence the shape of the ESPVR. More experimental and clinical observations are needed to understand the complex interrelation between the indexes presented in this study and how they can be used to predict HFpEF.

Conclusion
==========

An important feature of the mathematical formalism presented in this study is that it gives a new insight in the mechanics of ventricular contraction. The study of the ESPVR offers a rich collection of parameters that can be exploited in a noninvasive way in order to assess the state of the myocardium and the pump function of the heart. Not one of the indexes introduced in this study can allow full separation between all clinical groups, but some indexes appear to be more appropriate for some clinical groups than others. It turns out that bivariate (or multivariate) analysis of data is superior to univariate analysis (like using only EF) for the purpose of segregation between different clinical groups. The implication of these results for the study of the problem of HFpEF has been indicated and need further research for full assessment.

Supplementary Material
======================

The slope of the line CD is *E*~2~*~m~* = tanβ~2~ (see [Equation (2)](#fd2-cmc-suppl.1-2015-111){ref-type="disp-formula"} and [Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}) and it is given by Equation (25) of Shoucri.[@b32-cmc-suppl.1-2015-111] $$tan\beta_{2} = k_{w}\left( {\frac{1}{V_{m}} - \frac{1}{V_{m} + V_{\omega}} + \frac{\ln\left( \frac{V_{ed}}{V_{m}} \right) - \ln\left( \frac{V_{ed} + V_{\omega}}{V_{m} + V_{\omega}} \right)}{V_{ed} - V_{m}}} \right)$$

*V~ω~* is the volume of the myocardium assumed constant, the coefficient *k~w~* = (∂*W*/∂*I*)~av~ is an average value calculated by applying the mean value theorem, *W* is the pseudo-strain energy function of the passive medium of the myocardium, and *I* is the first strain invariant and appearing as a multiplicative geometrical factor. When we let *V~m~* → *V~om~* in [Equation (A1)](#fd19-cmc-suppl.1-2015-111){ref-type="disp-formula"}, we get the expression of the slope *E~m~* = tanα of the line BC (see [Equation (4)](#fd4-cmc-suppl.1-2015-111){ref-type="disp-formula"} and [Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}) $$tan\alpha = k_{w}\left( {\frac{1}{V_{om}} - \frac{1}{V_{om} + V_{\omega}} + \frac{\ln\left( \frac{V_{ed}}{V_{om}} \right) - \ln\left( \frac{V_{ed} + V_{\omega}}{V_{om} + V_{\omega}} \right)}{V_{ed} - V_{om}}} \right)$$

Notice that along the line BC, the slope tanα is constant, and consequently, *k~w~* is constant. We have assumed that along the ESPVR represented by the curve BDC in [Figure 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}, we can take *k~w~* as nearly constant. By writing *P~m~* = *P~isom~* -- (*P~isom~* -- *P~m~*) and by using [Equations (2)](#fd2-cmc-suppl.1-2015-111){ref-type="disp-formula"}, [(4)](#fd4-cmc-suppl.1-2015-111){ref-type="disp-formula"}, [(A1)](#fd19-cmc-suppl.1-2015-111){ref-type="disp-formula"}, and [(A2)](#fd20-cmc-suppl.1-2015-111){ref-type="disp-formula"}, we get for the expression of left ventricular pressure *P~m~* along the curve BDC $$P_{m} = k_{w}\left\lbrack {\left( {\frac{1}{V_{om}} - \frac{1}{V_{om} + V_{\omega}}} \right)(V_{ed} - V_{om}) - \left( {\frac{1}{V_{m}} - \frac{1}{V_{m} + V_{\omega}}} \right)(V_{ed} - V_{m})\ln\left( \frac{V_{m}}{V_{om}} \right) - \ln\left( \frac{V_{m} + V_{\omega}}{V_{om} + V_{\omega}} \right)} \right\rbrack$$

When *V~m~* → *V~ed~*, we get the expression for the peak isovolumic pressure $$P_{isom} = k_{w}\left\lbrack {\left( {\frac{1}{V_{om}} - \frac{1}{V_{om} + V_{\omega}}} \right)(V_{ed} - V_{om}) + \ln\left( \frac{V_{ed}}{V_{om}} \right) - \ln\left( \frac{V_{ed} + V_{\omega}}{V_{om} + V_{\omega}} \right)} \right\rbrack$$

By calculating ratios *P~isom~*/*P~m~* or tanα/tanβ~2~, the factor *k~w~* is eliminated. These ratios and similar ratios can be calculated in a noninvasive way by measuring the dimensions of the left ventricle. [Equations (A3)](#fd21-cmc-suppl.1-2015-111){ref-type="disp-formula"} and [(A4)](#fd22-cmc-suppl.1-2015-111){ref-type="disp-formula"} are used to calculate *V~om~* by using an iterative process as in Shoucri.[@b28-cmc-suppl.1-2015-111],[@b38-cmc-suppl.1-2015-111],[@b39-cmc-suppl.1-2015-111] For the slope tanγ = *dP~m~*/*dV~m~* of the tangent to the ESPVR, we get $$tan\gamma = k_{w}\left( {\frac{1}{V_{m}} - \frac{1}{V_{m} + V_{\omega}}} \right)\left( {\frac{V_{ed}}{V_{m}} + \frac{V_{ed} + V_{\omega}}{V_{m} + V_{\omega}}} \right)$$

When *V~m~* → *V~om~* in [Equation (A5)](#fd23-cmc-suppl.1-2015-111){ref-type="disp-formula"}, we get the slope tanγ~1~ of the tangent to the ESPVR at point B (see [Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}) $$tan\gamma_{1} = k_{w}\left( {\frac{1}{V_{om}} - \frac{1}{V_{om} + V_{\omega}}} \right)\left( {\frac{V_{ed}}{V_{om}} + \frac{V_{ed} + V_{\omega}}{V_{om} + V_{\omega}}} \right)$$

When *V~m~* → *V~ed~* in [Equation (A5)](#fd23-cmc-suppl.1-2015-111){ref-type="disp-formula"}, we get the slope tanγ~3~ of the tangent to the ESPVR at point C (see [Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}) $$tan\gamma_{3} = 2k_{w}\left( {\frac{1}{V_{om}} - \frac{1}{V_{om} + V_{\omega}}} \right)$$
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![Cross-section of a thick-walled cylinder representing the myocardium. The dotted circle represents the projection of a helical muscular fiber on the cross-section of the myocardium. *D~r~* is the radial active force/unit volume of the myocardium. *P* is the ventricular pressure, *P~o~* is the external pressure on the epicardium (assumed zero), *a* = inner radius, *b* = outer radius, *h* = *b* -- *a* = thickness of the myocardium.](cmc-suppl.1-2015-111f1){#f1-cmc-suppl.1-2015-111}

![Curvilinear ESPVR represented by the curve BDC, *B* is the intercept with the volume axis (corresponding to *V~om~*). For simplicity, the ventricular pressure *P~m~* is assumed constant during the ejection phase, *P~isom~* is the peak isovolumic pressure, *P~t~* corresponds to the ordinate of the intercept of the tangent with the vertical line AC. Stroke work *SW* ≈ *P~m~* (*V~ed~* -- *V~m~*), area *PE* = arc(BD)*V~m~B*. Total area *TW* = arc(BDC)AB, area CW = TW − PE − SW. The tangent (with slope tanγ) to the curve BDC at point (*P~m~*, *V~m~*) intersects the horizontal volume axis at *V~ot~*, the line DC (with slope tanβ~2~) intersects the horizontal volume axis at *V~o~*~2~, and the line BD (with slope tanβ~1~) intersects the horizontal volume axis at *V~om~*. Units of volume are ml and units of pressure are mmHg.](cmc-suppl.1-2015-111f2){#f2-cmc-suppl.1-2015-111}

![(Left) Variation of *y* = (*P~isom~* -- *P~m~*)/*P~m~* against *x* = *SV*/(*V~m~* − *V~o~*~2~); better segregation between clinical groups can be obtained by plotting *y*/std(*y*) against *x* (center) and (*y* + mean(*y*))/std(*y*) against (*x* + mean(*x*))/std(*x*) (right) for each clinical group; normal case \*, aortic stenosis *o*, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f3){#f3-cmc-suppl.1-2015-111}

![(Left) Relation between EF and *EF*/std(*EF*). (Right) Relation between (*V~m~* -- *V~o~*~2~)/*V~ed~* and \[(*V~m~* -- *V~o~*~2~)/*V~ed~*\]/std(\[(*V~m~* -- *V~o~*~2~)/*V~ed~*\]); normal case \*, aortic stenosis *o*, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f4){#f4-cmc-suppl.1-2015-111}

![(Left) Plot of (*P~isom~* -- *P~m~*)/*TW* versus stroke volume SV, no segregation of data between normal group (\*) and aortic stenosis (o) is observed. (Right) Segregation of data indicated by the horizontal line between normal group (\*) and aortic valvular regurgitation (+), and mitral valvular regurgitation (\^). Notice that by using the same coordinates, one can get different segregation of clinical data depending on the clinical groups considered; some indexes appear to be more appropriate to separate between some clinical groups than others.](cmc-suppl.1-2015-111f5){#f5-cmc-suppl.1-2015-111}

![(Left) Relation between SWR/SW and EF, notice that *SWR*/*SW* → 0 around *EF* → 0.33 ≈ 1/3. (Right) Relation between *SWR*/*SW* and tanγ/*e~am~*, notice that *SWR*/*SW* → 0 around tanγ/*e~am~* → 1; normal case \*, aortic stenosis o, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f6){#f6-cmc-suppl.1-2015-111}

![(Left) Percentage of occurrences of HF versus left ventricular ejection fraction LVEF (%) as calculated from Da Morta[@b3-cmc-suppl.1-2015-111], solid line corresponds to least square fit of data. (Right) Percentage of occurrences of HF versus percentage of ejection fraction 100\**EF* for five clinical groups, calculated with the least square fit shown by the solid curve on the left side, based on data taken from Dumesnil et al[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111]; normal case \*, aortic stenosis o, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f7){#f7-cmc-suppl.1-2015-111}

![(Left) Percentage of occurrences of HF versus 100\**SWR*/*SW*. (Right) Percentage of occurrences of HF versus 100\*(*V~ed~* -- *V~mx~*)/*SV*. Notice the minimum of the curve in each case around the normal group; normal group \*, aortic stenosis o, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f8){#f8-cmc-suppl.1-2015-111}

![Percentage of occurrences of HF / respective standard deviation of each group, for the five clinical groups considered in this study, versus left ventricular ejection fraction *EF* (%) (left), and *SWR/SW* (%) (right); normal case \*, aortic stenosis o, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f9){#f9-cmc-suppl.1-2015-111}

![(Left) Percentage of occurrences of HF versus 100\**SV*/(*V~ed~* − *V~om~*). (Right) Percentage of occurrences of HF versus 100\**SV*/(*V~ed~* − *V~o~*~2~). Notice the minimum of the curve in each case around the normal group; normal group \*, aortic stenosis o, aortic valvular regurgitation +, mitral valvular regurgitation \^, miscellaneous cardiomyopathies x.](cmc-suppl.1-2015-111f10){#f10-cmc-suppl.1-2015-111}

###### 

Results of calculation of different variables used in the study of various clinical groups.

                                       LVID MM   *V*~ω~ ML   *V~ed~* ML   *V~m~* ML   *V~om~* ML   *V~ot~* ML   tanα/e~am~   *P~isom~*/*P~m~*   *P~T~*/*P~M~*
  ------------------------------------ --------- ----------- ------------ ----------- ------------ ------------ ------------ ------------------ ---------------
  **Normal subjects**                                                                                                                           
  1                                    47        136.5       181.7        56.2        37.8         28.7         2.04         2.33               5.57
  2                                    52        203.8       247.8        76.6        51.5         39.1         2.05         2.35               5.57
  3                                    42        130.8       134.4        55          37.2         28.6         1.79         2.19               4.01
  4                                    46        135.5       170.9        51.5        34.6         26.3         2.07         2.36               5.74
  5                                    48        181         198.2        57          38.2         29           2.12         2.41               6.04
  6                                    51        154.5       229          94.2        64.1         49.1         1.75         2.14               3.99
  7                                    52        181         244.5        84          56.7         43.2         1.94         2.27               4.94
  8                                    45        177.3       167.1        50.5        33.8         25.7         2.1          2.4                5.71
  9                                    52        178.2       244          86.3        58.3         44.5         1.91         2.25               4.76
  **Aortic stenosis**                                                                                                                           
  1                                    38        211.4       112.9        17.6        11.6         8.7          2.61         2.78               11.7
  2                                    43        222.8       154.4        56.1        37.6         28.9         1.96         2.33               4.61
  3                                    38        166.8       108.1        26.9        17.9         13.6         2.31         2.56               7.06
  4                                    41        165.9       130.4        43.7        29.3         22.4         2.02         2.36               5.06
  5                                    41        194.3       133.8        42          28           21.4         2.11         2.43               5.46
  6                                    39        194.3       118.3        38          25.3         19.4         2.1          2.43               5.32
  7                                    42        326.1       156.2        50.1        33.3         25.5         2.12         2.46               5.32
  8                                    49        285.3       222.8        44          29.1         21.9         2.44         2.64               9.12
  9                                    58        358.3       355.2        121.5       81.6         62.4         1.98         2.32               4.96
  10                                   43        177.3       149.2        30.9        20.5         15.4         2.4          2.61               8.67
  11                                   49        306.2       225.9        103.9       70.3         54.5         1.67         2.13               3.47
  12                                   48        610.4       244.2        120         80.7         63.4         1.61         2.12               3.19
  **Aortic valvular regurgitation**                                                                                                             
  1                                    71        354.5       605.5        238.1       162.5        124.1        1.78         2.15               4.22
  2                                    59        305.2       364          90.97       60.8         45.94        2.22         2.46               7.06
  3                                    78        464.5       802.8        195         131          98.73        2.18         2.41               7.32
  4                                    57        317.5       334.2        112.3       75.53        57.65        1.99         2.32               5.06
  5                                    53        196.2       260.1        83.24       56.1         42.67        2.01         2.31               5.36
  6                                    60        413.3       395.5        116.5       77.94        59.26        2.12         2.41               5.87
  **Mitral valvular regurgitation**                                                                                                             
  1                                    76        488.2       751.9        284.6       193.4        147.5        1.83         2.19               4.41
  2                                    54        250.2       281.8        75.43       50.46        38.23        2.18         2.44               6.55
  3                                    58        193.4       331          142.7       97.62        74.66        1.68         2.09               3.77
  4                                    59        239.8       354.3        107.7       72.61        55.07        2.04         2.33               5.69
  **Miscellaneous cardiomyopathies**                                                                                                            
  1 (MVP)                              43        99.53       138.2        60.87       41.52        31.89        1.68         2.1                3.67
  2 (MVP)                              48        202.8       201.4        77.1        51.98        39.87        1.87         2.24               4.34
  3 (CM)                               68        264.5       524.5        322.1       224.9        174.4        1.2          1.77               2.37
  4 (IHSS)                             38        189.6       110.6        21.13       13.97        10.51        2.5          2.7                9.43
  5 (IHSS)                             28        53.1        41.75        4.823       3.182        2.368        2.69         2.81               16.04
  6 (IHSS)                             38        139.3       104.8        9.497       6.258        4.638        2.77         2.86               20.61
  7 (IHSS)                             38        263.5       117.6        41.45       27.62        21.256       2.03         2.4                4.77
  8 (IHSS)                             44        256.9       167.8        66.17       44.41        34.257       1.87         2.27               4.18
  9 (DSAS)                             42        165.9       139          31.87       21.18        16           2.33         2.57               7.75

**Abbreviations:** LVID, left ventricular internal diameter in diastole; *V~ω~*, volume of the myocardium; *V~ed~*, end-diastolic volume; *V~m~* ≈ *V~es~*, end-systolic volume; *V~om~* abscissa of the intercept of ESPVR with the volume axis; *V~ot~*, abscissa of the intercept of the tangent at point (*P~m~*, *V~m~*) to the ESPVR with the volume axis; *P~t~*, ordinate of the intercept of the tangent at point (*P~m~*, *V~m~*) to the ESPVR with the vertical axis through *V~ed~* ([Fig. 2](#f2-cmc-suppl.1-2015-111){ref-type="fig"}); *P~isom~*, peak isovolumic pressure; *P~m~*, left ventricular pressure corresponding to the ESPVR. Units of volume are ml, and units of pressure are mmHg. Calculation is based on data taken from Dumesnil et al.[@b7-cmc-suppl.1-2015-111]--[@b9-cmc-suppl.1-2015-111] MVP, mitral valve prolapsed; CM, cardiomyopathy; IHSS, idiopathic hypertrophic subaortic stenosis; DSAS, discrete subaortic stenosis.
